Pharmacopoeia Commission of India inks three MoUs with Nagaland government

image credit- pib

The Pharmacopoeia Commission of India (IPC), Ghaziabad, an autonomous institute under the Ministry of Health and Family Welfare, Government of India, has signed three Memorandums of Understanding (MoUs) with Nagaland Medical Council, Nagaland State Drug Control Administration (NSDCA), Department of Health and Family Welfare, Nagaland and State Pharmacy Council, Government of Nagaland.

The MoU was signed during a one-day training programme on monitoring in the pharma and materials sector. It was organised by the Pharmacopoeia Commission of India, Ghaziabad in collaboration with the Nagaland State Drug Control Administration (NSDCA), Department of Health and Family Welfare, Nagaland.

The event aimed to strengthen IPC's collaborative efforts in promoting public health by facilitating the use of Indian Pharmacopoeia reference substances and impurity standards in drug testing laboratories under NSDCA, safe and rational use of drugs, enhancing surveillance activities in the pharma and ingredients sector, and advancing patient safety initiatives in the state of Nagaland.

This MoU is expected to enhance professional engagement, establish adverse drug reaction (ADR) Monitoring Centres/Medical Devices Monitoring Centres/Monitoring Centres. It is expected to encourage wider participation in ADR reporting through establishment of Medical Device Monitoring Centres and strengthen the drug safety monitoring mechanism in the sector.

IPC is committed to provide all possible technical guidance and expert support for these initiatives. NSDCA and Nagaland State Pharmacy Council are also expected to cooperate with the Government of India to facilitate the establishment of Medical Colleges/Pharmacies in the country.